Reciprocal interactions between MK-801, sleep deprivation and recovery in modulating rat behaviour

Behavioural Brain Research

Volumn 216, Issue 1, 2011, Pages 180-185

  Dubiela, Francisco Paulino ^a   Messias, Melissa Fudoli ^a   Moreira, Karin Di Monteiro ^a   Zanlorenci, Lineane Helena Fernandes ^a   Grassl, Christian ^a   Filho, Roberto Frussa ^a   Nobrega, José N ^b   Tufik, Sergio ^a   Hipólide, Débora Cristina ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Locomotor activity; MK 801; NMDA receptor; Rat; Sleep deprivation

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; BRAIN REGION; CONTROLLED STUDY; GROOMING; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SLEEP DEPRIVATION; TRANQUILIZING ACTIVITY;

ANALYSIS OF VARIANCE; ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; BRAIN; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SLEEP DEPRIVATION;

EID: 78149407414     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.07.031     Document Type: Article

References (53)

1. Longordo F., Kopp C., Lüthi A. Consequences of sleep deprivation on neurotransmitter receptor expression and function. Eur J Neurosci 2009, 29:1810-1819.
2. Troncone L.R., Ferreira T.M., Braz S., Silveira Filho N.G., Tufik S. Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments. Psychopharmacology 1988, 94:79-83.
3. Tufik S., Troncone L.R., Braz S., Silva-Filho A.R., Neumann B.G. Does REM sleep deprivation induce subsensitivity of presynaptic dopamine or postsynaptic acetylcholine receptors in the rat brain?. Eur J Pharmacol 1987, 140:215-219.
4. Troncone L.R., Tufik S. Effects of selective adrenoceptor agonists and antagonists on aggressive behaviour elicited by apomorphine. dl-dopa and fusaric acid in REM-sleep-deprived rats. Physiol Behav 1991, 50:173-178.
5. Santos R., Carlini E.A. Serotonin receptor activation in rats previously deprived of REM sleep. Pharmacol Biochem Behav 1983, 18:501-507.
6. Hipólide D.C., Tufik S., Raymond R., Nobrega J.N. Heterogeneous effects of rapid eye movement sleep deprivation on binding to alpha- and beta-adrenergic receptor subtypes in rat brain. Neuroscience 1998, 86:977-987.
7. Hipólide D.C., Moreira K.M., Barlow K.B., Wilson A.A., Nobrega J.N., Tufik S. Distinct effects of sleep deprivation on binding to norepinephrine and serotonin transporters in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:297-303.
8. Nunes G.P., Tufik S., Nobrega J.N. Autoradiographic analysis of D1 and D2 dopaminergic receptors in rat brain after paradoxical sleep deprivation. Brain Res Bull 1994, 34:453-456.
9. Bettendorff L., Sallanon-Moulin M., Touret M., Wins P., Margineanu I., Schoffeniels E. Paradoxical sleep deprivation increases the content of glutamate and glutamine in rat cerebral cortex. Sleep 1996, 19:65-71.
10. Wang S.X., Li Q.S. Effects of sleep deprivation on gamma-amino-butyric acid and glutamate contents in rat brain. Di Yi Jun Yi Da Xue Xue Bao 2002, 22:888-890.
11. Murck H., Struttmann T., Czisch M., Wetter T., Steiger A., Auer D.P. Increase in amino acids in the pons after sleep deprivation: a pilot study using proton magnetic resonance spectroscopy. Neuropsychobiology 2002, 45:120-123.
12. Andine P., Widermark N., Axelsson R., Nyberg G., Olofsson U., Martensson E., et al. Characterization of MK-801-induced behavior as a putative rat model of psychosis. J Pharmacol Exp Ther 1999, 290:1393-1408.
13. Bertoglio L.J., Carobrez A.P. Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats. Psychopharmacology 2003, 170:335-342.
14. Blanchard D.C., Blanchard R.J., Carobrez A.P., Veniegas R., Rodgers R.J., Shepherd J.K. MK-801 produces a reduction in anxiety-related antipredator defensiveness in male and female rats and a gender-dependent increase in locomotor behavior. Psychopharmacology 1992, 108:352-362.
15. Bubser M., Keseberg U., Notz P.K., Schmidt W.J. Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats. Eur J Pharmacol 1992, 229:75-82.
16. Sturgeon R.D., Fessler R.G., Meltzer H.Y. Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur J Pharmacol 1979, 59:169-179.
17. Deakin J.F., Lees J., McKie S., Hallak J.E., Williams S.R., Dursun S.M. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. Arch Gen Psychiatry 2008, 65:154-164.
18. Rowland L.M., Bustillo J.R., Mullins P.G., Jung R.E., Lenroot R., Landgraf E., et al. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Am J Psychiatry 2005, 162:394-396.
19. Moghaddam B., Adams B., Verma A., Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 1997, 17:2921-2927.
20. Vyazovskiy V.V., Cirelli C., Pfister-Genskow M., Faraguna U., Tononi G. Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep. Nat Neurosci 2008, 11:200-208.
21. Kopp C., Longordo F., Nicholson J.R., Lüthi A. Insufficient sleep reversibly alters bidirectional synaptic plasticity and NMDA receptor function. J Neurosci 2006, 26:12456-12465.
22. McDermott C.M., Hardy M.N., Bazan N.G., Magee J.C. Sleep deprivation-induced alterations in excitatory synaptic transmission in the CA1 region of the rat hippocampus. J Physiol 2006, 570:553-565.
23. Ravassard P., Pachoud B., Comte J.C., Mejia-Perez C., Scoté-Blachon C., Gay N., et al. Paradoxical (REM) sleep deprivation causes a large and rapidly reversible decrease in long-term potentiation, synaptic transmission, glutamate receptor protein levels, and ERK/MAPK activation in the dorsal hippocampus. Sleep 2009, 32:227-240.
24. Paoletti P., Neyton J. NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol 2007, 7:39-47.
25. Suchecki D., Tufik S. Social stability attenuates the stress in the modified multiple platform method for paradoxical sleep deprivation in the rat. Physiol Behav 2000, 68:309-316.
26. Machado R.B., Hipolide D.C., Benedito-Silva A.A., Tufik S. Sleep deprivation induced by the modified multiple platform technique, quantification of sleep loss and recovery. Brain Res 2004, 1004:45-51.
27. Vezzani A., Serafini R., Stasi M.A., Caccia I., Tridico R.V., Samanin R. Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats. J Pharmacol Exp Ther 1989, 249:278-283.
28. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego. fourth ed.
29. Siegel S. Nonparametric statistics for the behavioral sciences 1956, McGraw-Hill, New York.
30. Tufik S., Andersen M.L., Bittencourt L.R., Mello M.T. Paradoxical sleep deprivation: neurochemical, hormonal and behavioral alterations. Evidence from 30 years of research. An Acad Bras Cienc 2009, 81:521-538.
31. Araujo N.P., Andersen M.L., Abilio V.C., Gomes D.C., Carvalho R.C., Silva R.H., et al. Sleep deprivation abolishes the locomotor stimulant effect of ethanol in mice. Brain Res Bull 2006, 69:332-337.
32. Goodwin P., Starr B.S., Starr M.S. Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801. J Neural Transm Park Dis Dement Sect 1992, 4:15-26.
33. Nilsson M., Carlsson A., Markinhuhta K.R., Sonesson C., Pettersson F., Gullme M., et al. The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:677-685.
34. Dubiela F.P., Oliveira M.G., Moreira K.M., Nobrega J.N., Tufik S., Hipolide D.C. Learning deficits induced by sleep deprivation and recovery are not associated with altered [(3)H]muscimol and [(3)H]flunitrazepam binding. Brain Res 2005, 1037:157-163.
35. Dubiela F.P., Oliveira M.G., Moreira K.M., Nobrega J.N., Tufik S., Hipolide D.C. Inverse benzodiazepine agonist beta-CCM does not reverse learning deficit induced by sleep deprivation. Neurosci Lett 2010, 469:169-173.
36. Godoi F.R., Oliveira M.G., Tufik S. Effects of paradoxical sleep deprivation on the performance of rats in a model of visual attention. Behav Brain Res 2005, 165:138-145.
37. Pellow S., Chopin P., File S.E., Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Method 1985, 14:149-167.
38. Ramos A., Pereira E., Martins G.C., Wehrmeister T.D., Izídio G.S. Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial. Behav Brain Res 2008, 193:277-288.
39. Boivin D.B. Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders. J Psychiatry Neurosci 2000, 25:446-458.
40. Chouinard S., Poulin J., Stip E., Godbout R. Sleep in untreated patients with schizophrenia: a meta-analysis. Schizophr Bull 2004, 30:957-967.
41. Ionov I.D. Synergistic effect of decreased opioid activity and sleep deprivation on head-twitch response in mice. Pharmacol Biochem Behav 2010, 96:48-51.
42. Campbell I.G., Feinberg I. Comparison of MK-801 and sleep deprivation effects on NREM, REM, and waking spectra in the rat. Sleep 1999, 22:423-432.
43. Guindalini C., Andersen M.L., Alvarenga T., Lee K., Tufik S. To what extent is sleep rebound effective in reversing the effects of paradoxical sleep deprivation on gene expression in the brain?. Behav Brain Res 2009, 201:53-58.
44. Cirelli C., Tononi G. Gene expression in the brain across the sleep-waking cycle. Brain Res 2000, 885:303-321.
45. Reith J., Cumming P., Gjedde A. Enhanced [3H]DOPA and [3H]dopamine turnover in striatum and frontal cortex in vivo linked to glutamate receptor antagonism. J Neurochem 1998, 70:1979-1985.
46. O'Neill M.F., Shaw G. Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice. Psychopharmacology 1999, 145:237-250.
47. Berridge K.C., Aldridge J.W. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists. Synapse 2000, 37:194-204.
48. Starr B.S., Starr M.S. Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors. Neuropharmacology 1986, 25:455-463.
49. Demontis M.G., Fadda P., Devoto P., Martellotta M.C., Fratta W. Sleep deprivation increases dopamine D1 receptor antagonist [3H]SCH 23390 binding and dopamine-stimulated adenylate cyclase in the rat limbic system. Neurosci Lett 1990, 117:224-227.
50. Frussa-Filho R., Gonçalves M.T., Andersen M.L., de Araujo N.P., Chinen C.C., Tufik S. Paradoxical sleep deprivation potentiates amphetamine-induced behavioural sensitization by increasing its conditioned component. Brain Res 2004, 1003:188-193.
51. Calzavara M.B., Andersen M.L., Fukushiro D.F., Lopez G.B., Abílio V.C., Tufik S., et al. Sleep rebound attenuates context-dependent behavioural sensitization induced by amphetamine. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1277-1282.
52. Ninan I., Kulkarni S.K. 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion. Eur J Pharmacol 1998, 358:111-116.
53. Su Y.A., Si T.M., Zhou D.F., Guo C.M., Wang X.D., Yang Y., et al. Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT 2A/2C receptors. Eur J Pharmacol 2007, 564:123-130.